HUP0300135A3 - Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails - Google Patents

Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails

Info

Publication number
HUP0300135A3
HUP0300135A3 HU0300135A HUP0300135A HUP0300135A3 HU P0300135 A3 HUP0300135 A3 HU P0300135A3 HU 0300135 A HU0300135 A HU 0300135A HU P0300135 A HUP0300135 A HU P0300135A HU P0300135 A3 HUP0300135 A3 HU P0300135A3
Authority
HU
Hungary
Prior art keywords
toe
active substance
topical treatment
substance combinations
finger nails
Prior art date
Application number
HU0300135A
Other languages
English (en)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HUP0300135A2 publication Critical patent/HUP0300135A2/hu
Publication of HUP0300135A3 publication Critical patent/HUP0300135A3/hu
Publication of HU228788B1 publication Critical patent/HU228788B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
HU0300135A 2000-03-09 2001-02-28 Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails HU228788B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10011081A DE10011081A1 (de) 2000-03-09 2000-03-09 Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
PCT/EP2001/002236 WO2001066145A1 (de) 2000-03-09 2001-02-28 Antiinfektive wirkstoffkombinationen und ihre verwendung zur topischen behandlung von pilzerkrankungen der fuss- und fingernägel

Publications (3)

Publication Number Publication Date
HUP0300135A2 HUP0300135A2 (hu) 2003-06-28
HUP0300135A3 true HUP0300135A3 (en) 2005-04-28
HU228788B1 HU228788B1 (en) 2013-05-28

Family

ID=7633836

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300135A HU228788B1 (en) 2000-03-09 2001-02-28 Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails

Country Status (29)

Country Link
US (2) US20010046478A1 (hu)
EP (1) EP1267932B1 (hu)
JP (1) JP4843176B2 (hu)
KR (1) KR100766738B1 (hu)
CN (1) CN1216642C (hu)
AT (1) ATE259660T1 (hu)
AU (2) AU2001246484B2 (hu)
BR (1) BRPI0108981B8 (hu)
CA (1) CA2402267C (hu)
CZ (1) CZ298718B6 (hu)
DE (2) DE10011081A1 (hu)
DK (1) DK1267932T3 (hu)
EE (1) EE04994B1 (hu)
ES (1) ES2211792T3 (hu)
HK (1) HK1054197B (hu)
HR (1) HRP20020731B1 (hu)
HU (1) HU228788B1 (hu)
IL (2) IL151519A0 (hu)
ME (2) ME00177B (hu)
MX (1) MXPA02008292A (hu)
NO (1) NO330245B1 (hu)
NZ (1) NZ521226A (hu)
PL (1) PL200700B1 (hu)
PT (1) PT1267932E (hu)
RS (1) RS50450B (hu)
RU (1) RU2261701C2 (hu)
SK (1) SK287076B6 (hu)
WO (1) WO2001066145A1 (hu)
ZA (1) ZA200207213B (hu)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040039030A1 (en) * 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639816A1 (de) * 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
JP4081312B2 (ja) * 2002-06-28 2008-04-23 佐藤製薬株式会社 外用抗真菌剤
BR0313343A (pt) * 2002-09-05 2005-07-12 Galderma Res & Dev Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal
DK1706128T3 (da) 2003-12-08 2010-10-04 Cpex Pharmaceuticals Inc Farmaceutiske sammensætninger og fremgangsmåder til insulin-behandling
US8309103B2 (en) * 2004-01-22 2012-11-13 Alparis, S.A. De C.V. Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
WO2006091908A2 (en) * 2005-02-22 2006-08-31 Nguyen Tim T Method for treatment of onychomycosis
US20060251593A1 (en) * 2005-04-07 2006-11-09 Work By Docs, Inc. Colored nail enamel treatment
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
MXPA05012961A (es) * 2005-11-30 2007-05-30 Fernando Ahumada Ayala Preparaciones para el cuidado de las unas que contienen clorhidrato de terbinafina.
KR20080098596A (ko) * 2006-01-02 2008-11-11 티엘티 메디컬 리미티드 조갑 질환 치료용 약학적 조성물
WO2007098591A2 (en) * 2006-03-02 2007-09-07 Nuvo Research Inc. Topical nail formulation
DE102008041049A1 (de) 2008-08-06 2010-02-11 Sonja Spohler Verwendung einer antimykotischen Zusammensetzung zur topischen Behandlung von Pilzerkrankungen von Fuß- und Fingernägeln
CN102319326A (zh) * 2011-07-23 2012-01-18 李玮 一种治疗脚癣的浸药卫生纸
WO2013106566A1 (en) * 2012-01-10 2013-07-18 Arch Wood Protection, Inc. Preservatives for wood
CA2775393C (en) * 2012-05-02 2014-04-29 Samy Saad Topical non-aqueous pharmaceutical formulations
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
KR101580077B1 (ko) * 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
WO2017029387A1 (en) * 2015-08-20 2017-02-23 Galderma Sa Method of improving visual appearance of nails affected by onychomycosis
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
MX2018015475A (es) * 2016-06-13 2019-07-12 Vyome Therapeutics Ltd Composiciones antifungicas sinérgicas y métodos de las mismas.
CN106726750A (zh) * 2016-12-09 2017-05-31 李晓光 一种环保抑菌护甲油及其制备方法
US20220211717A1 (en) * 2021-01-04 2022-07-07 Garry Alan Katz Topical treatment of fungal infections of the hair, skin, and nails

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US202098A (en) * 1878-04-09 Improvement in harrow and weed-cutter
US2134293A (en) * 1936-06-04 1938-10-25 Eastwood Nealley Corp Woven wire fabric for dandy rolls, cylinder molds, or the like, for paper making machines
US3968118A (en) * 1968-08-31 1976-07-06 Hoechst Aktiengesellschaft Process for the manufacture of 1-hydroxy-2-pyridones
US4185106A (en) * 1972-07-11 1980-01-22 Hoechst Aktiengesellschaft Pyridones as antidandruff agents
US4762703A (en) * 1982-01-25 1988-08-09 Dow Corning Corp. Nitrocellulose free nail lacquer composition
GB8302683D0 (en) * 1983-02-01 1983-03-02 Unilever Plc Skin treatment composition
WO1987002580A1 (en) * 1985-11-04 1987-05-07 Dermatological Products Of Texas Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
DE3779352D1 (de) * 1986-04-18 1992-07-02 Hoechst Ag 1-hydroxy-2-pyridone, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten, sowie bei der herstellung der 1-hydroxy-2-pyridone gebildete zwischenprodukte.
NL8601762A (nl) * 1986-07-07 1988-02-01 Bouke Jan Lange Werkwijze voor de reiniging en conditionering en eventuele medicinale behandeling van het haar en de hoofdhuid, een voor dit doel bruikbare tweefasen shampoo, alsmede een verpakking daarvoor.
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
CA2008775C (en) * 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
US5123107A (en) * 1989-06-20 1992-06-16 Mensch Jr William D Topography of CMOS microcomputer integrated circuit chip including core processor and memory, priority, and I/O interface circuitry coupled thereto
JPH0623087B2 (ja) * 1989-10-09 1994-03-30 花王株式会社 洗浄剤組成物
US5066484A (en) * 1990-04-30 1991-11-19 Revlon, Inc. Nail enamels containing glyceryl, glycol or citrate esters
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE4212105A1 (de) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
FR2697749B1 (fr) * 1992-11-12 1995-01-13 Oreal Composition cosmétique filmogène à base d'un copolymère chloré greffé résultant du greffage d'une polyoléfine chlorée et de monomères insaturés du type acrylique, styrénique et/ou vinylique.
DE4333893A1 (de) * 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
DE19518262A1 (de) * 1995-05-18 1996-11-21 Hoechst Ag Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen
US5424435A (en) * 1993-10-18 1995-06-13 Olin Corporation 1-hydroxy-6-substituted-2-pyridones
FR2718349B1 (fr) * 1994-04-07 1996-05-31 Oreal Compositions cosmétiques à appliquer sur l'ongle.
FR2719481B1 (fr) * 1994-05-05 1996-05-31 Oreal Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux.
DE19604190A1 (de) * 1996-02-06 1997-08-07 Hoechst Ag Nagelwachstumsfördernde Zubereitungen
US6169721B1 (en) * 1997-08-27 2001-01-02 Pioneer Electronic Corporation Two-disc laminated optical recording medium
DK0983037T3 (da) 1998-02-09 2003-09-01 Macrochem Corp Fungicid neglelak
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions

Also Published As

Publication number Publication date
PT1267932E (pt) 2004-07-30
NO20024271L (no) 2002-10-18
JP2003525910A (ja) 2003-09-02
RS50450B (sr) 2010-03-02
EE04994B1 (et) 2008-04-15
MXPA02008292A (es) 2002-12-09
BRPI0108981B8 (pt) 2021-05-25
HK1054197A1 (en) 2003-11-21
EE200200482A (et) 2004-02-16
CZ298718B6 (cs) 2008-01-09
IL151519A0 (en) 2003-04-10
NO20024271D0 (no) 2002-09-06
NZ521226A (en) 2004-08-27
ME00177B (me) 2011-02-10
KR100766738B1 (ko) 2007-10-15
RU2261701C2 (ru) 2005-10-10
HUP0300135A2 (hu) 2003-06-28
CA2402267A1 (en) 2001-09-13
HK1054197B (zh) 2005-12-16
US20010046478A1 (en) 2001-11-29
ZA200207213B (en) 2003-02-26
ES2211792T3 (es) 2004-07-16
CA2402267C (en) 2009-10-20
CZ20023001A3 (cs) 2002-11-13
JP4843176B2 (ja) 2011-12-21
HU228788B1 (en) 2013-05-28
ATE259660T1 (de) 2004-03-15
EP1267932A1 (de) 2003-01-02
PL359705A1 (en) 2004-09-06
SK287076B6 (sk) 2009-11-05
WO2001066145A1 (de) 2001-09-13
CN1416353A (zh) 2003-05-07
DK1267932T3 (da) 2004-06-01
AU4648401A (en) 2001-09-17
DE10011081A1 (de) 2001-09-13
MEP28808A (en) 2010-10-10
NO330245B1 (no) 2011-03-14
BR0108981B1 (pt) 2014-01-07
HRP20020731B1 (en) 2011-07-31
CN1216642C (zh) 2005-08-31
SK12762002A3 (sk) 2003-04-01
PL200700B1 (pl) 2009-01-30
BR0108981A (pt) 2003-06-03
IL151519A (en) 2011-07-31
AU2001246484B2 (en) 2005-04-14
YU64702A (sh) 2005-09-19
US20030086881A1 (en) 2003-05-08
KR20030016237A (ko) 2003-02-26
EP1267932B1 (de) 2004-02-18
HRP20020731A2 (en) 2004-12-31
DE50101510D1 (de) 2004-03-25

Similar Documents

Publication Publication Date Title
HUP0300135A3 (en) Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails
AU2001246484A1 (en) Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
AU2003265225A8 (en) Preparations for topical skin use and treatment
ATE429922T1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
CY2009002I1 (el) Χρηση αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη του πονου
EE200000253A (et) Seentevastase toimeaine kasutamine ravimite valmistamiseks, mis on ette nähtud mitteinvasiivsetest seenorganismidest tingitud haiguste raviks või vältimiseks
EP1299411A4 (en) METHOD FOR PREVENTING INJURY OF NEURAL TISSUE AND TREATING ALPHA SYNUCLEINE-RELATED DISEASES
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
EE05404B1 (et) Kinuklidiini derivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette n„htud respiratoorsete, kuseelundite v?i mao-soolte haiguste ravimiseks, ning seda sisaldav ravimkompositsioon
WO2004056307A3 (en) Disease treatment via antimicrobial peptide inhibitors
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
IL143699A0 (en) Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
AUPQ877300A0 (en) Topical treatment of skin
AU2003280918A8 (en) Rabbit skin comprising biological active substance and its use
EP1560572A4 (en) TOPICAL PEST FORMULATIONS AND METHODS OF TREATMENT
HUP0303311A3 (en) Highly flexible transdermal therapeutic system having nicotine as active substance
IL166016A0 (en) Topical treatment of skin diseases
IL160875A (en) Use of botulinum toxin for the manufacture of a medicament and a cosmetic for treating body odors
AU2003251407A8 (en) Topical treatment for skin irritation
SI1267932T1 (en) Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails
EP1322274A4 (en) LOCAL THERAPEUTIC SOLUTION FOR SKIN, AND METHODS OF USE
DE50208267D1 (de) Wirkstoff-kombination zur medikamentösen therapie der nikotinabhängigkeit
AU2001271257A1 (en) Use of a protein kinase c inhibitor to enhance the clinical efficacy of anti-neoplastic chemotherapeutic agents and radiation therapy
DE29815670U1 (de) Therapeutischer Schuh zur Beseitigung des Pilzbefalls an Zehen und Zehennägeln